HealthVault collaborating with AT&T

Share this article:
Microsoft's HealthVault has announced a collaboration deal with communications giant AT&T and computer platform service provider Covisint that will allow patients to share medical information with participating doctors via the Internet.

Through the initiative first announced in June, AT&T will provide broadband access and a dashboard for physicians to access the health care information, while Covisint will provide the underlying software that vets the patient info. Microsoft's HealthVault acts as the online storage system for the patient data. 
A release from the companies did not indicate how many doctors would initially participate.

The new computer exchange platform will also offer insights on constructing national, state and local health-information exchanges, officials for the companies said, and will provide services such as e-prescribing, clinical messaging and sharing of images such as X-rays and MRIs.

Earlier in June, Microsoft announced plans to collaborate with nonprofit HMO Kaiser Permanente in a pilot project open to Kaiser's 156,000 employees. 

If the pilot proves successful, a product linking Kaiser patient information with Microsoft's Health Vault would be offered to Kaiser's members.

Both Microsoft and Google have previously announced collaborative projects with health providers.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?